WuXi Biologics (Cayman), Inc. has 4,424 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is -1.6%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
WuXi Vaccines, a subsidiary of WuXi Biologics, focuses on human vaccine discovery, development and manufacture. An exciting new addition to the WuXi Biologics family, WuXi Vaccines will bring to the global vaccine industry the world-class integrated platforms and CDMO business model on which WuXi Biologics reputation is based. We provide an integrated global CDMO platform for vaccine development and manufacturing for global clients. In Dundalk, Ireland we are constructing a world class integrated vaccine manufacturing facility, which will include drug substance manufacturing (DS), drug product manufacturing (DP), Manufacturing Science and Technology Labs (MS&T) as well as Quality Control labs (QC), dedicated to manufacturing our partner’s vaccine products for the global market.
As of September 2025
WuXi Biologics
workforce metrics
Headcount
4.4k
Avg. Salary
$76.2k
Tenure
3.5yr
Growth Rate
-1.6%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of WuXi Biologics annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of WuXi Biologics annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?